Values as of: 2025-04-01
COMMON STOCK | Medical Care Facilities |
Last Closing
USD 101.28Change
0.00 (0.00)%Market Cap
USD 10.00BVolume
0.49MVerdict
Verdict
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| HCA | HCA Holdings Inc |
+1.30 (+0.38%) |
USD 79.32B |
| THC | Tenet Healthcare Corporation |
+3.78 (+2.83%) |
USD 12.13B |
| DVA | DaVita HealthCare Partners Inc |
+2.38 (+1.57%) |
USD 11.92B |
| UHS | Universal Health Services Inc |
+0.97 (+0.52%) |
USD 11.22B |
| CHE | Chemed Corp |
-3.88 (-0.63%) |
USD 8.72B |
| CON | Concentra Group Holdings Paren.. |
+0.52 (+2.36%) |
USD 2.93B |
| ARDT | Ardent Health Partners, Inc. |
-0.15 (-1.16%) |
USD 2.59B |
| NHC | National HealthCare Corporatio.. |
+0.18 (+0.19%) |
USD 1.90B |
| AGL | agilon health Inc |
-0.01 (-0.25%) |
USD 1.67B |
| GRDN | Guardian Pharmacy Services, In.. |
+0.52 (+2.48%) |
USD 1.25B |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| HLTH:AU | VanEck Global Healthcare .. | 2.31 % | 0.00 % |
-0.25 (1.13%) |
USD 0.06B |
| JPSV | Jpmorgan Active Small Cap.. | 1.85 % | 0.00 % |
+0.63 (+1.13%) |
USD 0.02B |
| OSCV | Opus Small Cap Value Plus | 0.00 % | 0.79 % |
+0.37 (+1.13%) |
USD 0.50B |
| OUSM | O’Shares U.S. Small-Cap.. | 0.00 % | 0.48 % |
+0.40 (+1.13%) |
USD 0.89B |
| GLRY | Inspire Faithward Mid Cap.. | 0.00 % | 0.00 % |
+0.38 (+1.13%) |
USD 0.08B |
| WSCR:LSE | UBS (Irl) ETF plc - MSCI .. | 0.00 % | 0.00 % |
-0.95 (1.13%) |
USD 0.01B |
| Market Performance vs. Industry/Classification (Medical Care Facilities) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 9.67% | 70% | C- | 88% | B+ | ||
| Dividend Return | 0.18% | 60% | D- | 5% | F | ||
| Total Return | 9.85% | 70% | C- | 88% | B+ | ||
| Trailing 12 Months | |||||||
| Capital Gain | 23.51% | 86% | B+ | 89% | A- | ||
| Dividend Return | 0.60% | 30% | F | 9% | A- | ||
| Total Return | 24.11% | 86% | B+ | 88% | B+ | ||
| Trailing 5 Years | |||||||
| Capital Gain | 105.04% | 65% | D | 68% | D+ | ||
| Dividend Return | 7.29% | 38% | F | 13% | F | ||
| Total Return | 112.33% | 65% | D | 62% | D | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 9.97% | 45% | F | 66% | D+ | ||
| Dividend Return | 11.18% | 45% | F | 63% | D | ||
| Total Return | 1.21% | 50% | F | 29% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 26.87% | 82% | B | 38% | F | ||
| Risk Adjusted Return | 41.62% | 64% | D | 56% | F | ||
| Market Capitalization | 10.00B | 81% | B- | 86% | B+ | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total free cash flow in the most recent four quarters.
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The company has under performed its peers on annual average total returns in the past 5 years.
The company had negative total cash flow in the most recent four quarters.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
